Prior efforts have attempted to improve on this model by selectively expressing the fusion in promyelocytes to mimic the suspected origin cell population in human APL but fail to induce leukemia or demonstrate enhanced self-renewal properties of PML-RARA-expressing cells despite a distinct gene expression signature (81). The gene discussed is PML; the disease is acute promyelocytic leukemia.